Neuraminidase-specific antibody responses are generated in naive and vaccinated newborn nonhuman primates following virus infection

Individuals younger than 6 months of age are at significant risk from influenza virus infection; however, there is currently no vaccine approved for this age group. Influenza virus neuraminidase (NA) has emerged as a potential additional target for vaccine strategies. In this study, we sought to und...

Descripción completa

Detalles Bibliográficos
Autores principales: Shultz, Patrick K., Crofts, Kali F., Holbrook, Beth C., Alexander-Miller, Martha A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819742/
https://www.ncbi.nlm.nih.gov/pubmed/33264104
http://dx.doi.org/10.1172/jci.insight.141655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819742/
https://www.ncbi.nlm.nih.gov/pubmed/33264104
http://dx.doi.org/10.1172/jci.insight.141655

Ejemplares similares